课题基金 / 基金详情

Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delaYed graft function trial (CINERGY) - Vanguard

Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delaYed graft function trial (CINERGY) - Vanguard
神经死亡捐献者中使用钙调神经磷酸酶抑制剂可减少肾延迟移植功能试验 (CINERGY) - Vanguard
批准号:
435602
负责人:
D'Aragon Frederick
金额:
$32.6万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-10-01 至 2023-04-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
End-stage organ failure presents complex issues and challenges for Canadian patients, clinicians and the health care system. Patients with end stage organ failure often require a transplant to save their lives. Unfortunately, there is a growing gap betwee
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金